Litcius/Paper detail

Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation

Ibrahim H. Eissa, Abdel‐Ghany A. El‐Helby, Hazem A. Mahdy, Mohamed M. Khalifa, H. El-Nagar, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Khaled El‐Adl

2020Bioorganic Chemistry86 citationsDOI

Topics & Concepts

ChemistrySorafenibIC50DoxorubicinDocking (animal)CytotoxicityStereochemistryActive siteIn vitroQuinazolinePharmacologyBiochemistryEnzymeCancer researchChemotherapyNursingSurgeryBiologyMedicineHepatocellular carcinomaQuinazolinone synthesis and applicationsHER2/EGFR in Cancer ResearchChemotherapy-induced cardiotoxicity and mitigation
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation | Litcius